Detecting importers who have insufficient data to support medicinal cannabis shelf-life claims is set to become a key focus for regulators in the lead-up to July’s Good Manufacturing Practice (GMP) reforms, it has emerged. Amid growing unease that overseas manufacturers and their local partners are cranking up imports before new rules come into force, questions are now being raised over product longevity claims.
Source: Cannabiz